“The current situation is unfortunate, but we fully understand the priorities set by the healthcare system,” says Anna Söderlund, CEO. “Our current focus is on the production and marketing of our two CE-marked products, Neo-Bilirubin and COVID19-LDH.”
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.